Rationale and Design of a Phase 3 Open-label Extension Study of Fixed Dose Combination of Aroxybutynin and Atomoxetine (AD109) in Obstructive Sleep Apnea
Authors: P.J. Strollo, S.R. Patel, S.D. Pittman, K. Mehta, A. Azarbarzin, J. Cronin, L. Taranto-Montemurro, R. Farkas